CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
Free plan and no credit card required.，推荐阅读服务器推荐获取更多信息
"I wouldn't have been worried if I had one bum cheek dragging on the floor. I didn't care at that point, I just wanted to go home," she said.，更多细节参见爱思助手下载最新版本
Returning nominees: